Carboxylic acid amides

Cayman Chemical mP-2 InhIbItr I 5mg

A hydroxamate-based, long-chain fatty acid that reversibly inhibits MMP-2 (Ki = 1.6 µM); attenuates cancer cell migration and has been shown to preserve blood-brain barrier function in a rat model of pneumococcal meningitis

Apexbio Technology LLC Oxamic acid 471-47-6 500mg

Oxamic acid is a small-molecule inhibitor targeting lactate dehydrogenase A (LDH-A) It is designed to inhibit LDH-A thereby disrupting the conversion of pyruvate to lactate during glycolysis and interfering with the glycolytic pathway Oxamic acid exerts its biological activity primarily through inhibition of LDH-A activity Based on these pharmacological properties oxamic acid holds research potential in studies of tumor metabolism investigation of metabolic vulnerabilities in cancer cells and screening of potential anti-cancer agents targeting glycolytic pathways

Apexbio Technology LLC Oxamic acid 471-47-6 100mg

Oxamic acid is a small-molecule inhibitor targeting lactate dehydrogenase A (LDH-A) It is designed to inhibit LDH-A thereby disrupting the conversion of pyruvate to lactate during glycolysis and interfering with the glycolytic pathway Oxamic acid exerts its biological activity primarily through inhibition of LDH-A activity Based on these pharmacological properties oxamic acid holds research potential in studies of tumor metabolism investigation of metabolic vulnerabilities in cancer cells and screening of potential anti-cancer agents targeting glycolytic pathways